Skip to main content
. Author manuscript; available in PMC: 2017 Oct 24.
Published in final edited form as: J Med Virol. 2008 Jan;80(1):72–79. doi: 10.1002/jmv.21043

TABLE II.

Key Features of Three NAT Assays Used in This Study

Method HCV b-DNA 3.0
HCV Monitor 2.0
HCV TaqMan
Signal amplification Target amplification (RT-PCR) Target amplification (RT-QPCR)
Measurement Fluorescence by luminometry End-point colorimetry Real time fluorescence
Sample input volume 50 μl 100 μl 10–140 μl
Linear range 103.0–106.9 IU/ml 102.8–105.9 IU/ml 102.6–106.5 IU/ml
Samples per run 48 (8) duplicates 12 48 (8) duplicates
Approximate cost per sample $70 $70 $8

The key features of each NAT employed in this study are listed above. The sample input for TaqMan can be adjusted depending on the nature of the sample. The number of duplicate standards and controls per run for b-DNA and TaqMan are shown in parenthesis. TaqMan chemistry allows the detection of amplification in the early stages of PCR, adding precision, whereas end-point measurements are taken at the end of the PCR. Both Monitor and TaqMan require manual total RNA extraction.